Want to see KIDS full AI Analyst Report?
KIDS Stock Chart & Stats
$16.75
-$0.10(-0.41%)
At close: 4:00 PM EST
$16.75
-$0.10(-0.41%)
Day’s Range― - ―
52-Week Range$14.42 - $23.70
Previous CloseN/A
Volume20.12K
Average Volume (3M)196.93K
Market Cap
$493.54M
Enterprise Value$431.30
Total Cash (Recent Filing)$50.86M
Total Debt (Recent Filing)$106.28M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Aug 05, 2026EPS Estimate
-0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.68
Shares Outstanding25,684,994
10 Day Avg. Volume194,659
30 Day Avg. Volume196,931
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)1.20
Price to Sales (P/S)1.76
P/FCF Ratio-26.10
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$25.00Price Target Upside49.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-1.18
Revenue Forecast (FY)$265.24M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~73% gross margins indicate durable product economics and pricing power in a specialized pediatric niche. High gross margins create room to absorb SG&A investments, support operating leverage as revenues scale, and underpin longer-term margin expansion if new higher-ASP products gain share.
Consistent Top-line Growth & InternationalDouble-digit organic growth and faster international expansion reflect broad demand and market penetration across pediatric orthopedics. Diverse geographies and record patient volume reduce single-market concentration, supporting multi-quarter revenue visibility and potential compounding revenue as new products scale globally.
Conservative Leverage And LiquidityLow leverage and meaningful liquidity provide a multi-quarter runway to fund operations, product launches, and set deployments without urgent refinancing. This balance-sheet flexibility materially reduces financial risk while the company executes on margin and cash-flow improvement initiatives.
Bears Say
Negative Cash FlowPersistent negative operating and free cash flow means the business still relies on external capital to fund growth and investments. Even with improvement, ongoing cash burn can constrain reinvestment pacing, increase funding risk if markets tighten, and delay durable free-cash-flow generation.
Ongoing GAAP LossesDespite high gross margins and improving adjusted EBITDA, GAAP net losses and negative net margins indicate the company has not converted operating improvements into sustained net profitability. Continued losses depress returns and require sustained margin/cost control to deliver positive shareholder returns.
Execution & Set-deployment RiskRevenue cadence depends on timely deployment of instrument sets and regulatory/supply timing for new products. Lower set deployments limit implant utilization and can shift revenue between periods, making revenue realization vulnerable to logistical delays and execution pacing during multi-region rollouts.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $14.42 and its highest was $23.70 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $493.54M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Aug 05, 2026 which is in 15 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Apr 30, 2026. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.455 by $0.005.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.3.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 25,684,994 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.455. Following the earnings report the stock price went up 3.785%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.00 (49.25% Upside)
$25.00 (49.25% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 254.2K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.79%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
KIDS Stock 12 Month Forecast
Average Price Target
$25.00
▲(49.25% Upside)
Technical Analysis
Orthofix Medical
―
Tandem Diabetes Care
―
Varex Imaging
―
Bioventus
―
Treace Medical Concepts
―
Ownership Overview
33.38% Insiders
13.08% Mutual Funds
3.13% Other Institutional Investors
42.65% Public Companies and
Individual Investors